Table IV.
Mutation | Amino acid change | Genotype | Controls (%) n=560 | Cases (%) n=443 | Adjusted OR (95% CI) | P-value | P-value for HWE in control |
---|---|---|---|---|---|---|---|
s3815675 | Synonymous | TT | 280 (50.0) | 218 (49.2) | Ref. | Ref. | 0.308 |
TC | 227 (40.5) | 179 (40.4) | 0.98 (0.73–1.30) | 0.877 | |||
CC | 53 (9.5) | 46 (10.4) | 1.15 (0.72–1.83) | 0.569 | |||
TC+TT | 507 (90.5) | 397 (89.6) | 0.86 (0.55–1.36) | 0.524 | |||
rs2287616 | Synonymous | TT | 277 (49.4) | 210 (47.4) | Ref. | Ref. | 0.545 |
TC | 225 (40.2) | 186 (42.0) | 1.06 (0.79–1.41) | 0.694 | |||
CC | 58 (10.4) | 47 (10.6) | 1.08 (0.69–1.72) | 0.715 | |||
TC+TT | 502 (89.6) | 396 (89.4) | 0.94 (0.61–1.46) | 0.793 | |||
rs2287617 | R299k | GG | 555 (99.1) | 440 (99.3) | Ref. | Ref. | 0.943 |
GA | 5 (0.9) | 3 (0.7) | 0.65 (0.14–3.06) | 0.582 | |||
AA | 0 (0.0) | 0 (0.0) | NA | NA | |||
GA+AA | 5 (0.9) | 3 (0.7) | 0.65 (0.14–3.06) | 0.582 | |||
rs2287622 | V444A | TT | 50 (8.9) | 39 (8.8) | Ref. | Ref. | 0.886 |
TC | 237 (42.3) | 187 (42.2) | 0.91 (0.55–1.51) | 0.709 | |||
CC | 273 (48.8) | 217 (49.0) | 0.92 (0.56–1.52) | 0.750 | |||
TC+TT | 287 (51.2) | 226 (51.0) | 1.00 (0.76–1.31) | 0.992 | |||
rs118109635 | A865V | CC | 551 (98.4) | 423 (95.5) | Ref. | Ref. | 0.627 |
CT | 9 (1.6) | 20 (4.5) | 2.67 (1.13–6.31) | 0.025 | |||
TT | 0 (0.0) | 0 (0.0) | NA | NA | |||
CT+TT | 9 (1.6) | 20 (4.5) | 2.67 (1.13–6.31) | 0.025 | |||
rs497692 | Synonymous | AA | 106 (18.9) | 55 (12.4) | Ref. | Ref. | 0.549 |
AG | 249 (44.5) | 194 (43.8) | 1.44 (0.96–2.17) | 0.079 | |||
GG | 205 (36.6) | 194 (43.8) | 1.79 (1.18–2.70) | 0.006 | |||
AG+GG | 454 (81.1) | 388 (87.6) | 1.60 (1.08–2.34) | 0.017 |
CI, confidence interval; HWE, HardyWeinberg Equilibrium; NA, not available; OR, odds ratio; PIS, primary intrahepatic stones; Ref., reference.